|
February 9, 2011 : Circassia Acquires Worldwide Rights to Novel Psoriasis and Atopic Dermatitis Treatment From Airmid Inc
July 8, 2009 : Xconomy: Kineta Acquires Multiple Sclerosis, Diabetes Drug Candidates to Test Unusual Biotech Strategy
July 7, 2009 : Kineta Acquires Novel Drug Candidates from Airmid for Potential Treatment of Multiple Sclerosis, Type 1 Diabetes and other Autoimmune Diseases
February 2, 2007 : Protein Angst
December 12, 2005: Natural Compounds Block Autoimmune Response in Diabetes, Arthritis
November 21, 2001: Sea Anemone Toxin Halts Experimental Multiple Sclerosis; Findings May Lead To New Treatments for Disease
December 7, 2001: Sea Anemone May Provide Drug to Treat Multiple Sclerosis |